LIFETECH SCI (01302.HK): Ruan Xingmei has been appointed as Executive Director.

Gelonghui, December 12丨LIFETECH SCI (01302.HK) announced that Ruan Xingmei has been appointed as the executive Director of the company, effective from December 12, 2024.

Gelonghui FinanceDec 12 18:02

Lifetech Sci (01302.HK): IBS absorbable drug-eluting coronary stent system announces the one-year follow-up results of Phase III clinical study.

Great Wall Power October 31st | Lifetech Sci (01302.HK) announced that the self-developed IBS absorbable drug-eluting coronary artery brackets system ("IBS coronary artery brackets") has successfully completed the Phase III clinical trial follow-up of one year, and on October 29, 2024, local time in the usa, Director Song Lei of the Fuwai Hospital of the Chinese Academy of Medical Sciences, on behalf of Academician Gao Runlin and all researchers, first presented the one-year major endpoint follow-up results of the Phase III clinical trial of IBS coronary artery brackets at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting to the global audience for the first time in 2024.

Gelonghui FinanceOct 31 08:09

Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.

"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.

Zhitong FinanceOct 29 09:30

lifetech sci [01302] is now trading at 1.48 Hong Kong dollars, with a rise of 10.45%.

As of 13:11, lifetech sci [01302] reported HK$1.48, up HK$0.14 or 10.45% from the previous closing price of HK$1.34, with a turnover of 92.7037 million Hong Kong dollars. The highest price today is HK$1.48, and the lowest price is HK$1.35. Based on yesterday's closing price, the 10-day average is HK$1.45, and the 50-day average is HK$1.49. The current PE ratio is 20.12 times, and the 14-day relative strength index is 24.73.

Golden MessengerOct 25 13:11

The pharmaceutical sector is performing strongly with the Hang Seng Healthcare Index up by 1.34%. Jingtailong Technology (02228) rose by 21.84%.

Golden Horse Financial News | Pharmaceutical stocks show strong performance, with the Hang Seng Healthcare Index up by 1.34%. Among them, Crystal Tai Technology quantumph-p (02228) rose by 21.84%, Yiming Angke (01541) rose by 9.94%, Zai Lab (09688) rose by 9.64%, Lifetech Sci (01302) rose by 5.22%, Lai Kai Medical (02105) rose by 5.52%, Tigermed (03347) rose by 5.36%. China Thai International stated that since October, there has been differentiation in the stock performance of the pharmaceutical industry, with components of the Hang Seng Healthcare Index showing a previous rise driven by easing policies.

Golden Guardian Financial NewsOct 25 10:43

There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.

Cumulative dividends exceed 0.3 billion over 4 years.

Gelonghui FinanceOct 9 10:04